- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01658085
Budget Impact of Harmonic FOCUS in Thyroidectomy (TIME)
Harmonic FOCUS Versus Conventional Technique in Total Thyroidectomy for Benign Thyroid Disease. A Randomized, Prospective Study
Study Design Multinodular Goiter (MNG) patients requiring surgery were referred to the Endocrine Surgery Unit.
Indirect laryngoscopy was routinely performed preoperatively to assess normal motility in vocal folds (VF). Ultrasounds (US) study was performed the month previous to surgery to evaluate thyroid volume. Eligible patients met the following criteria: to have MNG, age between 18 and 80 and consent to be included in the study. Exclusion criteria included previous neck surgery, vocal fold impairment, permanent or transitory NSAID or analgesic treatment, coagulation disorders and any cognitive impairment.
Eligible patients were proposed to enter a randomized study with 2 arms in which we compared the use of two harmonic scalpel devices: ACE14S and Harmonic Focus (Ethicon Endo-Surgery, Cincinnati, OH, USA).
The main endpoint was operative time. Secondary endpoints were total and relative (%) time of use of the device along thyroidectomy, recurrent laryngeal nerve (RLN) injury and hypocalcaemia (both persistent or temporary), number of ligatures, length of skin incision, postoperative pain according to a visual scale of pain, QOL after thyroidectomy (EuroQOL) and budget impact analysis.
All patients were operated on by 2 surgeons, one senior (responsible for the Endocrine Surgery Unit) and one junior under supervision.
Randomization Randomization was performed the same day of surgery at the OR by using a closed envelope. Patients were randomized to Group I (ACE14S) or Group II (HF) and allocated in a 1:1 proportion; they reminded blinded until the end of the study about the device used.
The haemostasis device was communicated to the surgeon previous to start surgery. Medical staff of the Endocrine Surgery Unit collected clinical data.
Surgical Technique Total thyroidectomy (TT), defined as total bilateral extracapsular lobectomy 9, was performed using HF or ACE14S for vessel division. Monopolar and bipolar forceps for cutting and coagulation were routinely used. Ties were used under surgeon's criteria according to size of the vessels and/or the need to obtain haemostasis in the vicinity of the RLN when bipolar forceps were not considered safe enough.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
OBJECTIVE:
To disclose the potential advantages and outcomes of the new Harmonic Focus (HF) device compared to Harmonic Scalpel ACE14S (ACE-14S) in benign thyroid surgery.
STUDY DESIGN:
Controlled randomized study.
METHODS:
Harmonic Focus was compared to former ACE14S device in patients undergoing total thyroidectomy for Multinodular Goiter. The primary endpoint was time of surgery. Secondary endpoints were time of use of the device, % of use along the procedure, number of ligatures, blood loss, hypocalcaemia, recurrent laryngeal nerve impairment, postoperative pain and quality of life.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Barcelona
-
L'Hospitalet, Barcelona, Spain, 08907
- Hospital UIniversitari de Bellvitge
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Eligible patients met the following criteria: to have MNG, age between 18 and 80 and consent to be included in the study.
Eligible patients were proposed to enter a randomized study with 2 arms in which we compared the use of two harmonic scalpel devices: ACE14S and Harmonic Focus (Ethicon Endo-Surgery, Cincinnati, OH, USA).
Description
Inclusion Criteria:
- Multinodular goiter (MNG), age between 18 and 80 and consent to be included in the study
Exclusion Criteria:
- previous neck surgery
- vocal fold impairment
- permanent or transitory NSAID or analgesic treatment,
- coagulation disorders
- any cognitive impairment.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study group: HARMONIC FOCUS®
Total thyroidectomy (total bilateral extracapsular lobectomy) for Multinodular Goiter with HARMONIC FOCUS®
|
Total thyroidectomy (total bilateral extracapsular lobectomy) for Multinodular Goiter with HARMONIC FOCUS®
Other Names:
|
|
Control group: ACE14S
Total thyroidectomy (total bilateral extracapsular lobectomy) for Multinodular Goiter with ACE14S
|
Total thyroidectomy (total bilateral extracapsular lobectomy) for Multinodular Goiter with ACE14S
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative time
Time Frame: Surgical time from skin incision to closure (about 70 minutes)
|
Operative time was measured from skin incision to removal of thyroid gland.
The percentage of time using the device along TT was calculated as follows: time of use of the device x 100/ operative time.
|
Surgical time from skin incision to closure (about 70 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total and relative (%) time of use of the device along thyroidectomy
Time Frame: From skin incision to removal of thyroid gland (about 30 minutes)
|
The percentage of time using the device along surgery was calculated as follows: time of use of the device x 100/ operative time.
|
From skin incision to removal of thyroid gland (about 30 minutes)
|
|
Recurrent laryngeal nerve (RLN) injury
Time Frame: From surgery to 6 months
|
Patients with laryngeal nerve injury were controlled monthly by indirect laryngoscopy till 6 months or healing.
|
From surgery to 6 months
|
|
hypocalcemia (both persistent or temporary)
Time Frame: Daily, from surgery to discharge (24h), or up to 6 months
|
Temporary hypocalcemia was measured daily, from surgery to discharge. Persistent hypocalcemia was followed up as follows:
|
Daily, from surgery to discharge (24h), or up to 6 months
|
|
postoperative pain according to a visual scale of pain
Time Frame: From surgery to 7 days
|
Pain evaluation was obtained at 24h and 7 days after surgery during postoperative control by using an analogue-visual scale reporting also the type of analgesic and the number of doses.
If there was any complication (including reoperation) that increased hospital stay, pain evaluation was performed each 24h until discharge.
|
From surgery to 7 days
|
|
QOL after thyroidectomy (EuroQOL)
Time Frame: 1st and 7th postoperative day
|
QOL was evaluated by completing EQ-5D questionnaire when patients were scheduled for the study (1st and 7th postoperative day)
|
1st and 7th postoperative day
|
|
Number of ligatures
Time Frame: Day of surgery
|
Number of ligatures during the procedure was measured to determine if its reduction would imply less surgical time consumption
|
Day of surgery
|
|
Length of skin incision
Time Frame: Day of surgery
|
Measured at the end of the operation, once the skin was closured.
|
Day of surgery
|
|
budget impact analysis
Time Frame: From surgery to discharge (24h)
|
costs of total thyroidectomy (all of them according to the prices of our center) and deducting those time-dependent costs saved with the reduction of OR time.
The following concepts were considered: personnel (with the same surgical team composition for both alternatives), anesthesia drugs, medical devices, overheads, repayment of the Harmonic generator, hospital stay and admission/discharge fees.
|
From surgery to discharge (24h)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Pablo Moreno, MD, PhD, Hospital UIniversitari de Bellvitge
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EO-0618
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multinodular Goiter
-
Genzyme, a Sanofi CompanyCompletedMultinodular GoiterCanada, United States, France, Brazil, Italy, Denmark, Germany, Netherlands
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Sarasota Memorial Health Care SystemTriSalus Life Sciences, Inc.Enrolling by invitationHyperthyroidism | Thyroid Disease | Thyroid Nodules | Multinodular Goiter | Hyperthyroidism; Goiter | Toxic Multinodular GoiterUnited States
-
The University of Hong KongCompletedNon Toxic Multinodular Goiter | High Intensity Focused Ultrasound | RAIHong Kong
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedTratment of Multinodular Goitre
-
The Cleveland ClinicCompletedPrimary Hyperparathyroidism | Multinodular GoiterUnited States
-
Universitair Ziekenhuis BrusselActive, not recruitingNodule Solitary Thyroid | Toxic Multinodular Goiter | Radioactive Iodine-Induced HypothyroidismBelgium
-
University of Roma La SapienzaCompletedThyroid Carcinoma | Thyroid Goiter | Multinodular Goiter | Graves DiseasesItaly
-
Istituto Auxologico ItalianoWithdrawnGraves Disease | Hyperthyroidism | Thyroid Cancer | Multinodular Goiter | Plummer Disease | Euthyroid Goiter | Basedow DiseaseItaly
-
Umraniye Education and Research HospitalUnknownThyroid Diseases | Thyroid Neoplasms | Thyroid Cancer, Papillary | Thyroid Carcinoma | Thyroid Nodule | Aspiration | Thyroid Goiter | Thyroid Papillary Carcinoma | Multinodular Goiter, Adolescent | Solitary Thyroid Nodule | Multifocal DysplasiaTurkey
Clinical Trials on HARMONIC FOCUS®
-
Yonsei UniversityUnknownHead and Neck CancerKorea, Republic of
-
S.B. Konya Education and Research HospitalUnknown
-
University of CalgaryCompletedOral Cavity Squamous Cell Carcinoma, Treated With SurgeryCanada
-
Centre hospitalier de l'Université de Montréal...Ethicon Endo-Surgery; Centre de Recherche du Centre Hospitalier de l'Université...Completed
-
Ethicon Endo-SurgeryCompletedBenign Disease Where Total Hysterectomy is IndicatedUnited States, Netherlands, United Kingdom
-
Seoul St. Mary's HospitalUnknownThyroid CancerKorea, Republic of
-
Hippocration General HospitalCompleted
-
Ospedale Regina ApostolorumCompletedBenign Thoroid Disease Requiring Total ThyroidectomyItaly
-
Ethicon Endo-SurgeryCompletedBenign or Malignant Disease Indicated for ColectomyUnited States, Belgium, United Kingdom
-
St Andrew's Centre for Plastic SurgeryWithdrawnBreast ReconstructionUnited Kingdom